- €7.64bn
- €7.70bn
- €1.54bn
- 99
- 19
- 96
- 87
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 19.42 | ||
PEG Ratio (f) | 1.74 | ||
EPS Growth (f) | 12.6% | ||
Dividend Yield (f) | 3.29% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 7.16 | ||
Price to Tang. Book | 8.58 | ||
Price to Free Cashflow | 42.99 | ||
Price to Sales | 4.81 | ||
EV to EBITDA | 15.84 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 30.98% | ||
Return on Equity | 39.18% | ||
Operating Margin | 27.6% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | €m | 1,078.1 | 1,041 | 1,340.6 | 1,189.7 | 1,542.4 | 1,624.89 | 1,982.09 | 7.97% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +10.22 | -13.41 | +82.85 | -46.46 | +92.25 | -9.33 | +64.53 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Orion Oyj is a Finland-based company engaged in the development, manufacture and marketing of pharmaceuticals and diagnostic tests. The Company operates, along with its subsidiaries, in two business segments: the Pharmaceuticals business segment develops, manufactures and markets pharmaceuticals and active pharmaceutical ingredients, and the Diagnostics business segment develops, manufactures and markets diagnostic tests. The Company’s business comprises two main divisions: Proprietary Products and Specialty Products. Its Proprietary Products consist of patented prescription products in three therapy areas: central nervous system diseases, oncology and critical care, and Easyhaler pulmonary drugs. The Company’s Specialty Products, which include the provision of generic prescription drugs and self-care products for basic healthcare. In addition the Company also produces veterinary medicines for pets and production animals.
Directors
- Timo Lappalainen CMG (59)
- Timo Maasilta VCH (66)
- Jari Karlson CFO (59)
- Satu Ahomaki SVP (54)
- Liisa Hurme SVP (53)
- Virve Laitinen SVP (48)
- Olli Huotari SVP (54)
- Outi Vaarala SVP (59)
- Jani Korhonen OTH
- Kari Jussi Aho IND (61)
- Pia Kalsta IND (50)
- Ari Lehtoranta IND (57)
- Hilpi Rautelin IND (59)
- Eija Ronkainen IND (54)
- Mikael Silvennoinen IND (64)
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- July 1st, 2006
- Public Since
- July 3rd, 2006
- No. of Shareholders
- 90,222
- No. of Employees
- 3,943
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
OMX Nordic Exchange - Helsinki
- Shares in Issue
- 140,693,334

- Address
- Orionintie 1A, ESPOO, 02200
- Web
- https://www.orion.fi/
- Phone
- +358 104261
- Contact
- Tuukka Hirvonen
- Auditors
- KPMG OY AB
Upcoming Events for ORNBV
Half Year 2025 Orion Oyj Earnings Release
Dividend For ORNBV.HE - 0.8200 EUR
Dividend For ORNAV.HE - 0.8200 EUR
Similar to ORNBV
Biohit Oyj
OMX Nordic Exchange - Helsinki
Oriola Oyj
OMX Nordic Exchange - Helsinki
FAQ
As of Today at 22:31 UTC, shares in Orion Oyj are trading at €54.30. This share price information is delayed by 15 minutes.
Shares in Orion Oyj last closed at €54.30 and the price had moved by +53.43% over the past 365 days. In terms of relative price strength the Orion Oyj share price has outperformed the FTSE Global All Cap Index by +49.59% over the past year.
The overall consensus recommendation for Orion Oyj is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Orion Oyj dividend yield is 3.02% based on the trailing twelve month period.
Last year, Orion Oyj paid a total dividend of €1.64, and it currently has a trailing dividend yield of 3.02%.Looking ahead, shares in Orion Oyj are due to go ex-dividend on 2025-10-15 and the next dividend pay date is 2025-10-23.
Orion Oyj are due to go ex-dividend on 2025-10-15 and the next dividend pay date is 2025-10-23. The historic dividend yield on Orion Oyj shares is currently 3.02%.
To buy shares in Orion Oyj you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €54.30, shares in Orion Oyj had a market capitalisation of €7.64bn.
Here are the trading details for Orion Oyj:
- Country of listing: Finland
- Exchange: HEX
- Ticker Symbol: ORNBV
Based on an overall assessment of its quality, value and momentum Orion Oyj is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Orion Oyj is €55.30. That is 1.84% above the last closing price of €54.30.
Analysts covering Orion Oyj currently have a consensus Earnings Per Share (EPS) forecast of €2.32 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Orion Oyj. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +22.36%.
As of the last closing price of €54.30, shares in Orion Oyj were trading +13.78% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Orion Oyj PE ratio based on its reported earnings over the past 12 months is 19.42. The shares last closed at €54.30.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Orion Oyj's management team is headed by:
- Timo Lappalainen - CMG
- Timo Maasilta - VCH
- Jari Karlson - CFO
- Satu Ahomaki - SVP
- Liisa Hurme - SVP
- Virve Laitinen - SVP
- Olli Huotari - SVP
- Outi Vaarala - SVP
- Jani Korhonen - OTH
- Kari Jussi Aho - IND
- Pia Kalsta - IND
- Ari Lehtoranta - IND
- Hilpi Rautelin - IND
- Eija Ronkainen - IND
- Mikael Silvennoinen - IND